ReviewJournal of clinical medicine2022

Aromatase Inhibitors and Risk of Metabolic and Cardiovascular Adverse Effects in Breast Cancer Patients-A Systematic Review and Meta-Analysis.

Kamila Boszkiewicz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.